BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning L, Shan G, Sun Z, Zhang F, Xu C, Lou X, Li S, Du H, Chen H, Xu G. Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease. Biomed Res Int. 2019;2019:3950628. [PMID: 31179321 DOI: 10.1155/2019/3950628] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Mainoli B, Hirota S, Edgington-mitchell LE, Lu C, Dufour A. Proteomics and Imaging in Crohn’s Disease: TAILS of Unlikely Allies. Trends in Pharmacological Sciences 2020;41:74-84. [DOI: 10.1016/j.tips.2019.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Park YM, Ha E, Gu KN, Shin GY, Lee CK, Kim K, Kim HJ. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease. Clin Transl Gastroenterol 2020;11:e00213. [PMID: 32764209 DOI: 10.14309/ctg.0000000000000213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Longo S, Chieppa M, Cossa LG, Spinelli CC, Greco M, Maffia M, Giudetti AM. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020;8:18. [PMID: 32784952 DOI: 10.3390/proteomes8030018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cheng H, Jin S, Huang S, Hu T, Zhao M, Li D, Wu B. Serum Proteomic Analysis by Tandem Mass Tag-Based Quantitative Proteomics in Pediatric Obstructive Sleep Apnea. Front Mol Biosci 2022;9:762336. [DOI: 10.3389/fmolb.2022.762336] [Reference Citation Analysis]
5 Neurath MF. COVID-19 and immunomodulation in IBD. Gut 2020;69:1335-42. [PMID: 32303609 DOI: 10.1136/gutjnl-2020-321269] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 54.0] [Reference Citation Analysis]
6 Navarro MN, Gómez de Las Heras MM, Mittelbrunn M. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing. Br J Pharmacol 2021. [PMID: 33817782 DOI: 10.1111/bph.15477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Monteleone G, Ardizzone S. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? J Crohns Colitis 2020;14:1334-6. [PMID: 32215548 DOI: 10.1093/ecco-jcc/jjaa061] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 40.0] [Reference Citation Analysis]
8 Park J, Jeong D, Chung YW, Kim DH, Cheon JH, Ryu JH. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis. Yonsei Med J 2020;61:891-4. [PMID: 32975064 DOI: 10.3349/ymj.2020.61.10.891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nie K, Yang YY, Deng MZ, Wang XY. Gastrointestinal insights during the COVID-19 epidemic. World J Clin Cases 2020; 8(18): 3934-3941 [PMID: 33024750 DOI: 10.12998/wjcc.v8.i18.3934] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol 2020;27:363-70. [PMID: 32732586 DOI: 10.1097/PAP.0000000000000276] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ferreira-Duarte M, Estevinho MM, Duarte-Araújo M, Magro F, Morato M. Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1787-95. [PMID: 33064147 DOI: 10.1093/ibd/izaa249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ahmed M. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. Gastroenterology Res 2020;13:89-95. [PMID: 32655724 DOI: 10.14740/gr1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang HG, Xie R, Ma TH, Yang XZ. Excessive anxiety in IBD patients is unnecessary for COVID-19. Clin Res Hepatol Gastroenterol 2020;44:e121-2. [PMID: 32409282 DOI: 10.1016/j.clinre.2020.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther 2020;52:54-72. [PMID: 32348598 DOI: 10.1111/apt.15779] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 20.0] [Reference Citation Analysis]
15 Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:276-83. [PMID: 32359205 DOI: 10.1111/apt.15804] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 41.5] [Reference Citation Analysis]
16 Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251:228-248. [PMID: 32418199 DOI: 10.1002/path.5471] [Cited by in Crossref: 284] [Cited by in F6Publishing: 280] [Article Influence: 142.0] [Reference Citation Analysis]
17 Xu F, Gao J, Orgil BO, Bajpai AK, Gu Q, Purevjav E, Davenport AS, Li K, Towbin JA, Black DD, Pierre JF, Lu L. Ace2 and Tmprss2 Expressions Are Regulated by Dhx32 and Influence the Gastrointestinal Symptoms Caused by SARS-CoV-2. J Pers Med 2021;11:1212. [PMID: 34834564 DOI: 10.3390/jpm11111212] [Reference Citation Analysis]
18 Teixeira TA, Bernardes FS, Oliveira YC, Hsieh MK, Esteves SC, Duarte-Neto AN, Kallas EG, Hallak J. SARS-CoV-2 and Multi-Organ damage - What men's health specialists should know about the COVID-19 pathophysiology. Int Braz J Urol 2021;47:637-46. [PMID: 33621014 DOI: 10.1590/S1677-5538.IBJU.2020.0872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chela H, Pasha SB, Wan XF, Ghouri YA. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2020. [PMID: 32876952 DOI: 10.1111/jgh.15241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zeidler JD, Hogan KA, Agorrody G, Peclat TR, Kashyap S, Kanamori KS, Gomez LS, Mazdeh DZ, Warner GM, Thompson KL, Chini CCS, Chini EN. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. Am J Physiol Cell Physiol 2022. [PMID: 35138178 DOI: 10.1152/ajpcell.00451.2021] [Reference Citation Analysis]
21 Guo Y, Wang B, Gao H, Gao L, Hua R, Xu JD. ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology. Front Mol Biosci 2021;8:708336. [PMID: 34631794 DOI: 10.3389/fmolb.2021.708336] [Reference Citation Analysis]
22 Piedra-Quintero ZL, Wilson Z, Nava P, Guerau-de-Arellano M. CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity. Front Immunol 2020;11:597959. [PMID: 33329591 DOI: 10.3389/fimmu.2020.597959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Baldan-Martin M, Chaparro M, Gisbert JP. Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1184-200. [PMID: 33529308 DOI: 10.1093/ibd/izaa352] [Reference Citation Analysis]
24 Gangadoo S, Rajapaksha Pathirannahalage P, Cheeseman S, Dang YTH, Elbourne A, Cozzolino D, Latham K, Truong VK, Chapman J. The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling. Int J Mol Sci 2021;22:1965. [PMID: 33671197 DOI: 10.3390/ijms22041965] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Joshi T, Ahmed A, Cholankeril G. Gastrointestinal manifestations of coronavirus disease 2019. Curr Opin Infect Dis 2021;34:471-6. [PMID: 34524198 DOI: 10.1097/QCO.0000000000000760] [Reference Citation Analysis]
26 Mansoor E, Khoudari G, Abou Saleh M, Elfadawy N, Cooper GS, Katz J, Faulx A. The Many Faces of COVID-19: Atypical Presentation of COVID-19 in a Patient With Crohn's Disease With Acute Diarrhea Leading to Severe Hypovolemic Hyponatremia-A Case Report. Am J Gastroenterol 2020;115:1730-1. [PMID: 32826570 DOI: 10.14309/ajg.0000000000000814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 de León-Rendón JL, Hurtado-Salazar C, Yamamoto-Furusho JK. Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations. Rev Gastroenterol Mex (Engl Ed) 2020;85:295-302. [PMID: 32536480 DOI: 10.1016/j.rgmx.2020.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Ning L, Li S, Gao J, Ding L, Wang C, Chen W, Shan G, Zhang F, Yu J, Xu G. Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy.Biomed Res Int. 2019;2019:1475705. [PMID: 31886172 DOI: 10.1155/2019/1475705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]